- Report
- November 2025
- 198 Pages
Global
From €3213EUR$3,545USD£2,738GBP
€3571EUR$3,939USD£3,042GBP
- Report
- December 2025
- 210 Pages
Global
From €5393EUR$5,950USD£4,595GBP
- Report
- October 2025
- 120 Pages
Global
From €5393EUR$5,950USD£4,595GBP
- Report
- January 2026
- 314 Pages
Global
From €2266EUR$2,500USD£1,931GBP
- Report
- February 2026
- 250 Pages
Global
From €4070EUR$4,490USD£3,468GBP
- Report
- February 2026
- 250 Pages
Global
From €4070EUR$4,490USD£3,468GBP
- Report
- February 2026
- 250 Pages
Global
From €4070EUR$4,490USD£3,468GBP
- Report
- July 2026
- 364 Pages
Global
From €5303EUR$5,850USD£4,518GBP
- Report
- July 2026
- 370 Pages
Global
From €5303EUR$5,850USD£4,518GBP
- Report
- July 2026
- 194 Pages
Global
From €5303EUR$5,850USD£4,518GBP
- Report
- July 2026
- 216 Pages
Global
From €5303EUR$5,850USD£4,518GBP
- Report
- July 2026
- 375 Pages
Global
From €5303EUR$5,850USD£4,518GBP
- Report
- July 2026
- 468 Pages
Global
From €5303EUR$5,850USD£4,518GBP
- Report
- June 2026
- 183 Pages
Global
From €3213EUR$3,545USD£2,738GBP
€3571EUR$3,939USD£3,042GBP
- Report
- June 2026
- 184 Pages
Global
From €3213EUR$3,545USD£2,738GBP
€3571EUR$3,939USD£3,042GBP
- Report
- October 2025
- 183 Pages
Global
From €3213EUR$3,545USD£2,738GBP
€3571EUR$3,939USD£3,042GBP
- Report
- May 2026
- 180 Pages
Global
From €4079EUR$4,500USD£3,475GBP
- Report
- November 2025
- 183 Pages
Global
From €4079EUR$4,500USD£3,475GBP
- Report
- February 2026
- 250 Pages
Global
From €4070EUR$4,490USD£3,468GBP
- Report
- February 2026
- 250 Pages
Global
From €4070EUR$4,490USD£3,468GBP

Liver cancer is a type of cancer that originates in the liver, an organ located in the upper right side of the abdomen. It is the fifth most common cancer worldwide and the third leading cause of cancer-related death. Symptoms of liver cancer can include abdominal pain, jaundice, and weight loss. Treatment options for liver cancer include surgery, chemotherapy, radiation therapy, and targeted therapy.
The oncology market for liver cancer is highly competitive, with a range of treatments available. Pharmaceutical companies are investing in research and development to develop new treatments and improve existing ones. Additionally, the market is seeing an increase in the number of clinical trials for new treatments.
Companies in the liver cancer market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more